Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New developments in sustained release drug delivery for the treatment of intraocular disease.

× No keyword cloud information.

43 in total

Review 1. The blood-ocular barriers.

Authors: J Cunha-Vaz
Journal: Surv Ophthalmol Date: 1979 Mar-Apr Impact factor: 6.048

Review 2. Osmotic opening of blood-brain and blood-ocular barriers.

Authors: S I Rapoport
Journal: Exp Eye Res Date: 1977 Impact factor: 3.467

3. Effects of different doses of glucocorticoids on growth of monolayer cultures of connective tissue.

Authors: V B Rozen; L S Chernin
Journal: Fed Proc Transl Suppl Date: 1965 Sep-Oct

4. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors: E L Larsson
Journal: J Immunol Date: 1980-06 Impact factor: 5.422

5. Vitreal, retinal, and pigment epithelial contribution to the posterior blood-ocular barrier.

Authors: W S Foulds; H Moseley; A Eadie; E McNaught
Journal: Trans Ophthalmol Soc U K Date: 1980-09

6. Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation.

Authors: M Barza
Journal: Scand J Infect Dis Suppl Date: 1978

7. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation.

Authors: M S Blumenkranz; A Claflin; A S Hajek
Journal: Arch Ophthalmol Date: 1984-04

8. Dexamethasone inhibition of experimental endothelial cell proliferation in retinal venules.

Authors: J T Heffernan; S Futterman; R E Kalina
Journal: Invest Ophthalmol Vis Sci Date: 1978-06 Impact factor: 4.799

Review 9. The clinical pharmacology of methotrexate: new applications of an old drug.

Authors: W A Bleyer
Journal: Cancer Date: 1978-01 Impact factor: 6.860

10. Inhibition of intraocular proliferations with intravitreal corticosteroids.

Authors: Y Tano; G Sugita; G Abrams; R Machemer
Journal: Am J Ophthalmol Date: 1980-01 Impact factor: 5.258

6 in total

1. Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.

Authors: Alessandro Grattoni; Haifa Shen; Daniel Fine; Arturas Ziemys; Jaskaran S Gill; Lee Hudson; Sharath Hosali; Randy Goodall; Xuewu Liu; Mauro Ferrari
Journal: Pharm Res Date: 2010-07-01 Impact factor: 4.200

2. Enhancement of scleral macromolecular permeability with prostaglandins.

Authors: R N Weinreb
Journal: Trans Am Ophthalmol Soc Date: 2001

3. A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Authors: Jithan V Aukunuru; Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Randall C Clark; Uday B Kompella
Journal: Pharm Res Date: 2002-03 Impact factor: 4.200

Review 4. An overview of clinical and commercial impact of drug delivery systems.

Authors: Aaron C Anselmo; Samir Mitragotri
Journal: J Control Release Date: 2014-04-18 Impact factor: 9.776

5. Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury.

Authors: Simonetta Papa; Raffaele Ferrari; Massimiliano De Paola; Filippo Rossi; Alessandro Mariani; Ilaria Caron; Eliana Sammali; Marco Peviani; Valentina Dell'Oro; Claudio Colombo; Massimo Morbidelli; Gianluigi Forloni; Giuseppe Perale; Davide Moscatelli; Pietro Veglianese
Journal: J Control Release Date: 2013-11-10 Impact factor: 9.776

6. Distribution of Triamcinolone Acetonide after Intravitreal Injection into Silicone Oil-Filled Eye.

Authors: Ma Da; Kenneth K W Li; Kevin C Chan; Ed X Wu; David S H Wong
Journal: Biomed Res Int Date: 2016-07-14 Impact factor: 3.411

6 in total